Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles-Reference-Cited by-同舟云学术

Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles

Published:2011-05 Issue:1 Volume:152 Page:84-89
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Gao Zhong-Gao,Tian Li,Hu Jun,Park In-Suh,Bae You Han

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. Recent progress in tumor pH targeting nanotechnology;Lee;J. Control. Release,2008

2. “Seed and soil” revisited: mechanisms of site-specific metastasis;Hart;Cancer Metastasis Rev.,1982

3. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis;Fidler;Cancer Metastasis Rev.,1986

4. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX;Fodstad;Int. J. Cancer,1988

5. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor;Aslakson;Cancer Res.,1992

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Approaches and Innovative Strategies in Laboratory Animal Models for Cancer Research: A Comprehensive Review;Düzce Tıp Fakültesi Dergisi;2024-06-30

2. Immobilized doxorubicin and ribociclib carbamate linkers encaged in surface modified cubosomes spatially target tumor reductive environment to enhance antitumor efficacy;Biomaterials Advances;2023-12

3. Erythrocyte−cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer;Biomaterials Advances;2023-08

4. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer;Recent Patents on Anti-Cancer Drug Discovery;2023-08

5. Calcium Orthophosphate in Liposomes for Co-Delivery of Doxorubicin Hydrochloride/Paclitaxel in Breast Cancer;Molecular Pharmaceutics;2023-06-29